Neisseria meningitidis compositions and methods thereof
US-8986710-B2 · Mar 24, 2015 · US
Immunogenic fusion polypeptides
US9802987B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9802987-B2 |
| Application number | US-201414773324-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 5, 2014 |
| Priority date | Mar 8, 2013 |
| Publication date | Oct 31, 2017 |
| Grant date | Oct 31, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
In one aspect, the invention relates to an isolated polypeptide including the amino acid sequence of a carrier polypeptide and the amino acid sequence of an ORF2086 polypeptide. In another aspect, the invention relates to an immunogenic conjugate including ORF2086 polypeptide and a carrier polypeptide. The invention further includes immunogenic compositions and methods for inducing an immune response against Neisseria meningitidis in a mammal.
First claim
Opening claim text (preview).
The invention claimed is: 1. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 2. 2. The isolated polypeptide according to claim 1 , wherein the amino acid sequence is encoded by SEQ ID NO: 4. 3. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 8. 4. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 14. 5. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 16. 6. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 18.
Assignees
Inventors
Classifications
Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT] · CPC title
from Streptococcus pneumoniae (Pneumococcus) (Streptokinase C07K14/3153) · CPC title
- C07K14/22Primary
from Neisseriaceae (F) · CPC title
Streptococcus · CPC title
Neisseria · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9802987B2 cover?
- In one aspect, the invention relates to an isolated polypeptide including the amino acid sequence of a carrier polypeptide and the amino acid sequence of an ORF2086 polypeptide. In another aspect, the invention relates to an immunogenic conjugate including ORF2086 polypeptide and a carrier polypeptide. The invention further includes immunogenic compositions and methods for inducing an immune re…
- Who is the assignee on this patent?
- Pfizer
- What technology area does this patent fall under?
- Primary CPC classification C07K14/22. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).